{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T20:15:37Z","timestamp":1771964137005,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009664","name":"Spanish Society of Cardiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.carrev.2019.06.008","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T08:58:04Z","timestamp":1561453084000},"page":"52-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Percutaneous Mitral Valve Repair Vs. Stand-Alone Medical Therapy in Patients with Functional Mitral Regurgitation and Heart Failure"],"prefix":"10.1016","volume":"21","author":[{"given":"Tom\u00e1s","family":"Benito-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Est\u00e9vez-Loureiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro A.","family":"Villablanca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizio","family":"Armeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Iglesias-G\u00e1rriz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Minguito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Garrote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando P\u00e9rez","family":"de Prado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Tundidor-Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Gualis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Fern\u00e1ndez-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.carrev.2019.06.008_bb0005","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jacc.2011.08.067","article-title":"Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) high risk study","volume":"59","author":"Whitlow","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.carrev.2019.06.008_bb0010","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.jacc.2010.11.043","article-title":"The acute hemodynamic effects of MitraClip\u00ae therapy","volume":"57","author":"Siegel","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.carrev.2019.06.008_bb0015","article-title":"Impact of transcatheter mitral valve repair on left ventricular remodeling in secondary mitral regurgitation: a meta-analysis","volume":"2","author":"Megaly","year":"2018","journal-title":"Struct Hear"},{"issue":"12","key":"10.1016\/j.carrev.2019.06.008_bb0020","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00392-017-1150-x","article-title":"Functional status and quality of life after transcatheter mitral valve repair: a prospective cohort study and systematic review","volume":"106","author":"Iliadis","year":"2017","journal-title":"Clin Res Cardiol"},{"issue":"6","key":"10.1016\/j.carrev.2019.06.008_bb0025","first-page":"651","article-title":"Survival advantage of MitraClip\u00ae over medical treatment in patients with mitral regurgitation: a meta-analysis","volume":"26","author":"Benito-Gonz\u00e1lez","year":"2017","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.carrev.2019.06.008_bb0030","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation","author":"Obadia","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2019.06.008_bb0035","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","author":"Stone","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.carrev.2019.06.008_bb0040","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.carrev.2019.06.008_bb0045","doi-asserted-by":"crossref","unstructured":"Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000;283(15):2008\u20132012. doi:https:\/\/doi.org\/10.1001\/jama.283.15.2008.","DOI":"10.1001\/jama.283.15.2008"},{"issue":"7829","key":"10.1016\/j.carrev.2019.06.008_bb0050","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ."},{"key":"10.1016\/j.carrev.2019.06.008_bb0055","unstructured":"Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Published 2013."},{"issue":"2","key":"10.1016\/j.carrev.2019.06.008_bb0060","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.amjcard.2015.10.044","article-title":"Comparison of percutaneous mitral valve repair versus conservative treatment in severe functional mitral regurgitation","volume":"117","author":"Giannini","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2019.06.008_bb0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijcard.2016.01.212","article-title":"Real-world cost effectiveness of MitraClip\u00ae combined with medical therapy versus medical therapy alone in patients with moderate or severe mitral regurgitation","volume":"209","author":"Armeni","year":"2016","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.carrev.2019.06.008_bb0070","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/13696998.2016.1227828","article-title":"Clinical outcomes and economic impact of transcatheter mitral leaflet repair in heart failure patients","volume":"20","author":"Asgar","year":"2017","journal-title":"J Med Econ"},{"issue":"22","key":"10.1016\/j.carrev.2019.06.008_bb0075","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.jacc.2014.02.537","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology Heart Association task force on practice guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.carrev.2019.06.008_bb0080","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/eurheartj\/ehm001","article-title":"What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?","volume":"28","author":"Mirabel","year":"2007","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.carrev.2019.06.008_bb0085","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.athoracsur.2005.08.080","article-title":"Chronic ischemic mitral regurgitation: repair, replace or rethink?","volume":"81","author":"Borger","year":"2006","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.carrev.2019.06.008_bb0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1312808","article-title":"Mitral-valve repair versus replacement for severe ischemic mitral regurgitation","volume":"370","author":"Acker","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.carrev.2019.06.008_bb0095","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/eurjhf\/hfp051","article-title":"Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction","volume":"11","author":"Agricola","year":"2009","journal-title":"Eur J Heart Fail"},{"issue":"15","key":"10.1016\/j.carrev.2019.06.008_bb0100","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","article-title":"Percutaneous repair or surgery for mitral regurgitation","volume":"364","author":"Feldman","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2019.06.008_bb0105","series-title":"Interventional cardiology","article-title":"Percutaneous treatment of mitral and tricuspid regurgitation in heart failure","author":"Benito-Gonz\u00e1lez","year":"2017"},{"key":"10.1016\/j.carrev.2019.06.008_bb0110","first-page":"heartjnl","article-title":"Five-year outcomes of transcatheter reduction of significant mitral regurgitation in high-surgical-risk patients","author":"Kar","year":"2018","journal-title":"Heart."},{"key":"10.1016\/j.carrev.2019.06.008_bb0115","article-title":"Left atrial hemodynamics and left ventricular remodeling -predictors of outcomes after transcatheter mitral valve repair with the MitraClip\u00ae device","author":"Lazkani","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.carrev.2019.06.008_bb0120","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004909","article-title":"Impact of forward stroke volume response on clinical and structural outcomes after percutaneous mitral valve repair with MitraClip","volume":"10","author":"Kubo","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.06.008_bb0125","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000070420.51787.A8","article-title":"Left ventricular remodeling and ventricular arrhythmias after myocardial infarction","author":"St John Sutton","year":"2003","journal-title":"Circulation."},{"issue":"25","key":"10.1016\/j.carrev.2019.06.008_bb0130","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1161\/CIRCULATIONAHA.106.642892","article-title":"Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial","volume":"114","author":"Saxon","year":"2006","journal-title":"Circulation."},{"issue":"18","key":"10.1016\/j.carrev.2019.06.008_bb0135","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jacc.2008.07.043","article-title":"Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy. The InSync ICD (Implantable Cardioverter-Defibrillator) Italian registry","volume":"52","author":"Di Biase","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2019.06.008_bb0140","first-page":"POS0354","article-title":"Impact of percutaneous mitral valve repair in ventricular arrhythmic burden of patients with severe mitral regurgitation and heart failure","author":"Ascencio Lemus","year":"2017","journal-title":"EuroPCR Par\u00eds"},{"issue":"4","key":"10.1016\/j.carrev.2019.06.008_bb0145","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jacc.2012.09.038","article-title":"Rehospitalization for heart failure: problems and perspectives","volume":"61","author":"Gheorghiade","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.carrev.2019.06.008_bb0150","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","article-title":"Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance","volume":"30","author":"Zoghbi","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"issue":"7","key":"10.1016\/j.carrev.2019.06.008_bb0155","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ehjci\/jet105","article-title":"Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging","volume":"14","author":"Lancellotti","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2019.06.008_bb0160","unstructured":"Kang RT, Mitral F. Angiotensin receptor neprilysin inhibitor for functional mitral regurgitation: the PRIME study."}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919303689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919303689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:16:18Z","timestamp":1761560178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838919303689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1553838919303689"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2019.06.008","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Percutaneous Mitral Valve Repair Vs. Stand-Alone Medical Therapy in Patients with Functional Mitral Regurgitation and Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2019.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}